Adherence to drug label recommendations for avoiding drug interactions causing statin-induced myopathy--a nationwide register study.
<h4>Purpose</h4>To investigate the extent to which clinicians avoid well-established drug-drug interactions that cause statin-induced myopathy. We hypothesised that clinicians would avoid combining erythromycin or verapamil/diltiazem respectively with atorvastatin or simvastatin. In pati...
Guardado en:
Autores principales: | Jennifer Settergren, Birgit Eiermann, Buster Mannheimer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3cfc5db8c1fa4e22beaab8f79163cde6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy
por: Pierandrea Vinci, et al.
Publicado: (2021) -
An open science pathway for drug marketing authorization-Registered drug approval.
por: Florian Naudet, et al.
Publicado: (2021) -
PREVENTIVE EFFECT OF LONG ACTING Β2-AGONISTS ON STATIN INDUCED MYOPATHIES
por: Abdullah Qamar, et al.
Publicado: (2018) -
Statin induced myopathy and myalgia: time trend analysis and comparison of risk associated with statin class from 1991-2006.
por: Mariam Molokhia, et al.
Publicado: (2008) -
Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions.
por: Jon D Duke, et al.
Publicado: (2012)